Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AEZS save search
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -2.88%
H: 6.93%
C: 5.94%
approval
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -1.5%
H: 6.09%
C: 5.58%
year ongoing financial results growth hormone
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
Published: 2024-03-12 (Crawled : 18:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -1.96%
H: 4.75%
C: 2.25%
approved
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
Published: 2024-02-26 (Crawled : 12:30) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -0.53%
H: 5.32%
C: 3.72%
company agreement
Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business
Published: 2024-02-23 (Crawled : 14:00) - globenewswire.com
SYIEY | $27.456 0.05% 31K
|
Manufacturing
|
| O: -0.23%
H: 0.11%
C: 0.08%
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -1.98%
H: 11.18%
C: 11.18%
business update ongoing technology
Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris
Published: 2024-02-15 (Crawled : 23:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: -3.0%
meeting
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro
Published: 2024-02-15 (Crawled : 23:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: -3.0%
management meeting
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company
Published: 2023-12-14 (Crawled : 13:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 3.46%
H: 0.0%
C: -2.68%
company
Aeterna Zentaris Reports Third Quarter 2023 Financial Results
Published: 2023-11-09 (Crawled : 13:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 1.07%
H: 2.64%
C: 1.32%
financial results
Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -1.04%
H: 6.32%
C: -3.16%
ceo conference
Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-05 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 3.19%
H: 1.16%
C: 1.16%
conference global
Aeterna Zentaris Reports Second Quarter 2023 Financial Results
Published: 2023-08-09 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -2.36%
H: 3.1%
C: 3.1%
financial results
Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update
Published: 2023-07-13 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 1.05%
H: 1.55%
C: -0.34%
update pipeline
Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series
Published: 2023-07-05 (Crawled : 13:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -4.61%
H: 9.2%
C: 9.2%
Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholders
Published: 2023-06-14 (Crawled : 20:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: -3.33%
meeting results
Aeterna Zentaris Announces Virtual 2023 Meeting of Shareholders
Published: 2023-05-15 (Crawled : 20:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -2.18%
H: 2.76%
C: -5.16%
meeting
Aeterna Zentaris Reports First Quarter 2023 Financial Results
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -2.58%
H: 5.26%
C: 1.32%
financial results
Aeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT Trial
Published: 2023-04-05 (Crawled : 12:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -3.64%
H: 5.65%
C: -1.21%
macrilen update trial
Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-03-23 (Crawled : 12:20) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 1.13%
H: 3.73%
C: 1.49%
year financial results
Pharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)
Published: 2023-03-16 (Crawled : 12:20) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 0.75%
H: 4.09%
C: 2.23%
test diagnostic growth market hormone
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.